Screener
Edwards Lifesciences EW Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsMiscellaneousNoncurrent.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Acquisition options | 79.3 | 125.9 |
| Long-term prepaid royalties | 91.3 | 93.3 |
| Fair value of derivatives | 14.2 | 5.8 |
| Other long-term assets | 16.8 | 16.7 |
| $738.9 | $730.2 | |
| Accrued and other liabilities | ||
| Employee compensation and withholdings | $265.4 | $467.5 |
| Taxes payable | 204.9 | 192.5 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Edwards Lifesciences's other non-current assets?
- Edwards Lifesciences (EW) reported other non-current assets of $16.8M in Q1 2026.
- How has Edwards Lifesciences's other non-current assets changed year-over-year?
- Edwards Lifesciences's other non-current assets decreased by 18.0% year-over-year, from $20.5M to $16.8M.
- What is the long-term trend for Edwards Lifesciences's other non-current assets?
- Over 2 years (2023 to 2025), Edwards Lifesciences's other non-current assets has grown at a 11.2% compound annual growth rate (CAGR), from $13.5M to $16.7M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Edwards Lifesciences's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude